Trial · NCT07896356
Family-partnered Delirium Prevention, Detection, and Management in the ICU
NCT07896356, Not applicable, Not yet recruiting, University of Calgary
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Family-partnered Delirium Prevention, Detection, and Management in the ICU. Trials, record NCT07896356. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07896356
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Family-partnered Delirium Prevention, Detection, and Management in the ICU
- NCT number
- NCT07896356
- Status
- Not yet recruiting
- Phases
- Not applicable
- Enrollment
- 1,344 participants, estimated
- Lead sponsor
- University of Calgary
- Conditions
- Delirium, Intensive Care Unit Delirium, Post Intensive Care Unit Syndrome, Post Intensive Care Unit Syndrome Family
- Interventions
- Standard of Care, Delirium Education, Prevention, and Management
- First posted
- 2026-10-27
- Last updated
- 2026-10-27
Source ClinicalTrials.gov
Registered outcomes6
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Family member symptoms of depression and anxiety | 3-months post-ICU discharge | Change in the proportion of major depressive disorder and generalized anxiety symptamology in family members of critical ill patients measured by the Patient Health Questionnaire-Anxiety and Depression Scale (PHQ-ADS) scores, compared between control and intervention |
| Secondary | Clinically significant depression symptoms (family) | Up to five days and at 3-months post patient ICU discharge | Change in proportion of major depressive disorder symptamology in family members of critically ill patients measured by the Patient Health Questionnaire-9 (PHQ-9) scores, compared between control and intervention |
| Secondary | Clinically significant symptoms anxiety (family) | Up to five days and at 3-months post patient ICU discharge | Change in proportion of generalized anxiety symptomatology in family members of critically ill patients measured by the Generalized Anxiety Disorder-7 (GAD-7) scores, compared between the control group and the intervention |
| Secondary | Delirium or coma free days (patients) | Up to five days | Clinical delirium assessment measured by the Confusion Assessment Method for the ICU (CAM-ICU) or the Intensive Care Delirium Screening Checklist (ICDSC) scores, compared between control and intervention Coma free days measured by the number of days after enrolment that a patient is alive without delirium or coma, compared between control and intervention |
| Secondary | Time to both ICU and hospital discharge (patients) | Up to five days | Number of days between ICU admission and discharge from the ICU and/or hospital, compared between control and intervention |
| Secondary | Cumulative dose of pain medications, antipsychotics, and sedatives (patients) | Up to five days | Medications measured in milligrams per 24 hours, compared between control and intervention |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07896356
GET https://conductscience.org/api/trials/v1/NCT07896356/registered